US Economy Faces Challenges if Restrictions on Foreign Talent Increase, Biotech CEO Says

A CEO of a US-based biotech company said at a recent economic forum in Washington, DC, that restricting the ability to bring in foreign talent could hinder company growth and negatively impact the US economy. The CEO highlighted that many immigrants come to the US to pursue opportunities and that US laws have historically adapted to facilitate this.

The executive stated that limiting immigration could reduce the country’s "regenerative capacity," referring to its ability to innovate and grow.

The company, based in Cambridge, Massachusetts, recruits scientists, engineers, and medical professionals from around the world. The CEO noted that immigration has been a foundational element of the country's development over the past 250 years. Additionally, a vice chairman of a major technology company spoke at the same event about the company's reliance on foreign workers and its use of the H-1B visa program.

He expressed support for using the visa program to bring in skilled workers who contribute to economic growth, while cautioning against its use for less skilled labor.

The biotech CEO’s comments reflect concerns that changes to immigration policy could affect the availability of skilled workers in sectors critical to innovation.

The technology executive’s remarks underscore the importance of visa programs in maintaining a skilled workforce for economic productivity. Both speakers emphasized the role of immigration in sustaining the US economy and innovation ecosystem, suggesting that policies restricting foreign talent could have broader economic implications.